Dr. Ishwaria Subbiah is a Palliative Care physician and medical oncologist in the Department of Palliative, Rehabilitation, and Integrative Medicine in the Division of Cancer Medicine at MD Anderson Cancer Center. Dr. Subbiah is uniquely qualified for this role, having completed 3 clinical fellowships at MD Anderson first in developmental therapeutics, then in Medical Oncology and most recently in Palliative Medicine. With this robust foundation in phase I and II clinical trial design, novel therapeutics including immunotherapy and targeted therapies, fundamentals of medical oncology practice, and symptom management, Dr. Subbiah cultivates a clinical practice and research focus on supportive care driven by patient reported outcomes (PROs) for all patients with particular emphasis on the older adults and clinical trial participation.
- Chair, Patient Survey Informatics Committee, governing patient reported outcomes (PROs) initiatives at MD Anderson including oversight over all remote symptom monitoring and questionnaires administered to patients via the EHR.
- Clinical Lead of Patient-Reported Outcomes, Operations Lead (oD3CODE), MD Anderson Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE)
- Member, Older Adult Oncology Clinical Practice Guidelines Committee, National Comprehensive Cancer Network (NCCN), Fort Washington, PA, 6/2018-present
- Associate Editor, Symptom Control and Palliative Care, American Cancer Society journal Cancer, June 2021-present.
- American Cancer Society (ACS) Clinician Scientist Development Grant Awardee. 11/1/2019-present
- Member, Editorial Board, Journal of Geriatric Oncology, Elsevier, 2020-present
- Rapidly developed and implemented an institution-wide remote symptom monitoring program for patients with cancer and COVID-19 infection. Outreach: >2,000 patients with cancer and COVID-19. Developed and implemented a separate institution-wide initiative for PRO-based symptom monitoring after COVID-19 vaccine and its association with vaccine outcomes for patients with cancer. Impact: >29,000 symptom questionnaires returned from >6400 patients with cancer, the largest such PRO-symptom monitoring program for patients with cancer in the world.
Education / Honors
- Andrew Sabin Family Foundation Fellow, 2019
- Clinical Internship, Internal Medicine, Albany Medical Center, Albany, NY, 2008-2009
- Clinical Residency, Internal Medicine, University of Texas (UT) Health Science Center at Houston, TX, 2009-2011
- Clinical Fellowship, Investigational Cancer Therapeutics, UT MD Anderson Cancer Center, Houston, TX, 2011-2012
- Clinical Fellowship, Medical Oncology, UT MD Anderson Cancer Center, Houston, TX, 2012-2015
- Clinical Fellowship, Hospice and Palliative Medicine, UT MD Anderson Cancer Center, Houston, TX, 2015-2016
- Rice University Doerr Institute for New Leaders, MD Anderson Leadership Institute, Houston, TX, Certificate, 2019, CoachRice: A Leadership Coaching Program
- Butler-Williams Scholar, National Institutes of Health (NIH), National Institute on Aging (NIA), Bethesda, MD, 2019
- Jones School of Business, Rice University, Houston, TX, Graduate Certificate in Health Care Management, 2018
- St. George’s University, St. George, GND, MD, 2008, Doctor of Medicine
- Johns Hopkins University, Baltimore, MD, MS, 2005, Biotechnology
- Johns Hopkins University, Baltimore, MD, BS, 2004, Molecular and Cellular Biology